Dr Reddys Laboratories Share Price Today - Live Blog for September 04, 2025

Dr Reddys Laboratories Ltd's shares saw an increase of 0.14%, reaching the current market price of ₹1,255.00. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's share price has dropped by -0.24%, a development that warrants careful analysis. Presently trading at ₹1,253.70, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd observed a -0.02% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,256.70. The stock has a PE ratio of 18.5500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.14% gain, with the share price now at ₹1,258.20. Notably, the stock's PE ratio stands at 18.5500, and its Return on Equity (ROE) is 16.8559%.

The share price of Dr Reddys Laboratories Ltd remained fixed, with no fluctuations, and is currently at ₹1,256.00. Investors may choose to investigate the factors contributing to this price stability and whether it presents an investment opportunity.

Dr Reddys Laboratories Ltd's share price has fallen by -0.10%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,256.15, and market participants are assessing the implications. The stock has a PE ratio of 18.5500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a significant 0.05% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,257.05 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd's share price has dropped by -0.17%, a development that warrants careful analysis. Presently trading at ₹1,257.75, investors are assessing whether this presents an opportunity or a risk.

The stock of Dr Reddys Laboratories Ltd is facing a -0.28% decline and is currently trading at ₹1,260.70 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a -0.59% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,264.25. Investors should examine the factors driving this decline. The stock's PE ratio is 18.5500, whereas the industry PE ratio stands at 34.3044.

Dr Reddys Laboratories Ltd experienced a -0.07% downturn in its share price, and it's currently trading at ₹1,270.25. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.02%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,270.25 per share.

The stock of Dr Reddys Laboratories Ltd suffered a -0.06% drop, and it's now trading at ₹1,266.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd stock price decreased by -0.06%, with the current market value at ₹1,266.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd experienced a substantial 0.05% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,267.30, making it an appealing option for investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.02% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,267.30, making it an appealing option for investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.16%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,266.90 per share.

After a significant 0.13% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,265.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a remarkable 0.02% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,263.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.5500, while the industry's PE ratio is 34.3044.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.05%, reaching a current market price of ₹1,264.20. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.08% boost, with the current market value at ₹1,265.00 per share. This surge has not gone unnoticed by investors.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.08% upswing and is currently trading at ₹1,265.00, indicating strong market sentiment.

Dr Reddys Laboratories Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,265.20, making it an appealing option for investors.

Demonstrating a commendable 0.08% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,264.90. In terms of valuation, the stock maintains a PE ratio of 18.5500, while the industry PE ratio stands at 34.3044.

Dr Reddys Laboratories Ltd witnessed a notable 0.13% surge in its share price and is presently trading at ₹1,264.45, captivating the attention of market participants.

With a -0.71% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,263.00. The stock is currently trading at a PE of 18.5500, while the industry PE is 34.3044, prompting investors to assess its value proposition.